The FORMAMP project consists of 16 partners from 5 different European countries. This multidisciplinary team includes academic research groups, clinicians, industry as well as regulatory authorities.



RISE Research Institutes of Sweden 

RISE Chemistry, Materials and Surfaces is the coordinator of FORMAMP and managers of several Work Packages. Research activites include development of lipidbased nanoformulations for AMPs as well as formulation of topical and pulmonary delivery systems, in vitro cytotoxicity studies and in vivo models for skin infections.


Lund University, Sweden

Department of Clinical Sciences contributes with clinical expertise for skin and soft tissue infections and tuberculosis as well as expertise releated to AMPs. Several effect studies are performed at LU including in vitro studies for immunomodulatory effects and protease resistence as well as both in vitro and in vivo models for tuberculosis.


Uppsala University, Sweden

Department of Pharmacy contributes with general AMP expertise as well as research activitities focusing on development of micro- and nanogels as carriers for AMPs.


 Ulm University, Germany

Department of Synthesis and Characterization of Inorganic Materials manages and performs research activities related to mesoporous silica as carrier systems for AMPs.

 AZGLogo_24bit_Color (2)

University Medical Center Groeningen, Netherlands

Department of Biomedical Engineering develops in vitro biofilm models for evaluation of the formulations developed within the FORMAMP Project.

 pergamum_logono tag

Pergamum, Sweden

Pergamum is a SME developing AMPs for clinical use. In FORMAMP they contributes with their AMP clinical lead candidates and expertise related to development of these into pharmaceutical Products.


Medical Products Agency, Sweden

MPA contributes with independent expertise related to regulathory aspects of pharmaceutical product development.


SP Process Development, Sweden

SPPD manages the work related to CMC including regulathory aspects, strategies for process development and scale-up. In addtion, they are involved in formulation development and analytical methods for AMPs.


Polymer Factory, Sweden

Polymer Factory is a SME company focusing on dendrimers. They are suppling dentritic materials to the project and work in close collaboration with KTH.


University of Angers, France

Biomimetic Micro and Nano Medicine (MINT) is managing the work related to lipidbased nanoformulations and is developing Lipid Core Nanocapsules for delivery of AMPs.


University Hospital of Angers, France

Department of Biology of Infectious Agents and Pharmaco-Toxicology is involved in performing in vitro antibacterial effect studies of the formulations developed within the Project.


KTH Royal Institute of Technology, Sweden

Department of Fibre and Polymer Technology manages the work related to polymer-based nanoformulations and is focusing on development of dendrimers for AMPs.

 Inhalation sciences logoEPS

Inhalation Sciences Sweden, Sweden

Inhalation Sciences is a SME  focused on pharmaceutical administration via inhalation. In FORMAMP they contribute with research and expertise related to pulmonary pharmacokinetics as well as aerosolization properties of dry powder formulations.


XSpray Microparticles, Sweden

XSpray is a SME that have a developed technology to optimize particles for inhalation. They also contribute with expertise in particle engineering of peptide based pharmaceutical compounds.



Adenium Biotech, Denmark

Adenium Biotech is a pharmaceutical SME developing AMPs for lung infections. In FORMAMP the company contributes with their AMP clinical lead candidates and expertise related to development of these into pharmaceutical Products.


PolyPeptide Laboratories, Sweden

The PolyPeptide Group is a world leader in the industrial/commercial-scale manufacture of proprietary and generic GMP and non-GMP peptides. In FORMAMP PolyPeptides is responsible for synthesis of AMPs and expertise related to  production and scale-up of AMPs .